Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Cell Biol Int. 2021 May;45(5):1098-1110. doi: 10.1002/cbin.11556. Epub 2021 Feb 4.
Accurate relative gene expression analysis by reverse transcription-quantitative polymerase chain reaction relies on the usage of suitable reference genes for data normalization. The RNA content of small extracellular vesicles including exosomes is growingly considered as cancer biomarkers. So, reliable relative quantification of exosomal messenger RNA (mRNA) is essential for cancer diagnosis and prognosis applications. However, suitable reference genes for accurate normalization of a target gene in exosomes derived from cancer cells are not depicted yet. Here, we analyzed the expression and stability of eight well-known reference genes namely GAPDH, B2M, HPRT1, ACTB, YWHAZ, UBC, RNA18S, and TBP in exosomes-isolated from the liver (Huh7, HepG2, PLC/PRF/5) and breast (SK-BR-3) cancer cell lines using five different algorithms including geNorm, BestKeeper, Delta Ct, NormFinder, and RefFinder. Our results showed that ACTB, TBP, and HPRT1 were not expressed in exosomes-isolated from studied liver and breast cancer cell lines. The geNorm and BestKeeper algorithms indicated GAPDH and UBC as the most stable candidates. Moreover, Delta Ct and NormFinder algorithms showed YWHAZ as the most stable reference genes. Comprehensive ranking calculated by the RefFinder algorithm also pointed out GAPDH, YWHAZ, and UBC as the first three stable reference genes. Taken together, this study validated the common reference genes stability in exosomal mRNA derived from liver and breast cancer cell lines for the first time. We believe that this study would be the first step in finding more stable reference genes in exosomes that triggers more accurate detection of exosomal biomarkers.
准确的逆转录定量聚合酶链反应(RT-qPCR)相对基因表达分析依赖于合适的参考基因进行数据归一化。包括外泌体在内的小细胞外囊泡的 RNA 含量越来越被认为是癌症生物标志物。因此,对于癌症诊断和预后应用,准确地对外泌体信使 RNA(mRNA)进行相对定量是至关重要的。然而,尚未描述用于准确归一化癌细胞来源的外泌体中靶基因的合适参考基因。在这里,我们使用 geNorm、BestKeeper、Delta Ct、NormFinder 和 RefFinder 等五种不同的算法分析了 8 个已知的参考基因(GAPDH、B2M、HPRT1、ACTB、YWHAZ、UBC、RNA18S 和 TBP)在肝癌(Huh7、HepG2、PLC/PRF/5)和乳腺癌(SK-BR-3)癌细胞系中分离的外泌体中的表达和稳定性。我们的结果表明,ACTB、TBP 和 HPRT1 在研究的肝癌和乳腺癌细胞系分离的外泌体中不表达。geNorm 和 BestKeeper 算法表明 GAPDH 和 UBC 是最稳定的候选基因。此外,Delta Ct 和 NormFinder 算法显示 YWHAZ 是最稳定的参考基因。RefFinder 算法综合排名也指出 GAPDH、YWHAZ 和 UBC 是前三个最稳定的参考基因。总之,这项研究首次验证了肝和乳腺癌细胞系中外泌体 mRNA 中常见参考基因的稳定性。我们相信,这项研究将是寻找外泌体中更稳定的参考基因的第一步,这将引发对外泌体生物标志物更准确的检测。